Literature for peptidase A01.014: candidapepsin SAP1

(References are filtered for relevance to Inhibitor. To remove the filter click here. See explanation.)

2013
1. Cadicamo,C.D., Mortier,J., Wolber,G., Hell,M., Heinrich,I.E., Michel,D., Semlin,L., Berger,U., Korting,H.C., Holtje,H.D., Koksch,B. and Borelli,C.
   Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans
   Biochem Pharmacol85, 881-887. PubMed  Europe PubMed DOI  I
2011
2. Braga-Silva,L.A. and Santos,A.L.S.
   Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis
   Curr Med Chem18, 2401-2419. PubMed  Europe PubMed DOI  I
3. Buchold,C., Hemberger,Y., Heindl,C., Welker,A., Degel,B., Pfeuffer,T., Staib,P., Schneider,S., Rosenthal,P.J., Gut,J., Morschhauser,J., Bringmann,G. and Schirmeister,T.
   New cis-configured aziridine-2-carboxylates as aspartic acid protease inhibitors
   ChemMedChem6, 141-152. PubMed  Europe PubMed DOI  I
2006
4. Majer,F., Pavlickova,L., Majer,P., Hradilek,M., Dolejsi,E., Hruskova-Heidingsfeldova,O. and Pichova,I.
   Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling
   Biol Chem387, 1247-1254. PubMed  Europe PubMed DOI  P  I
2003
5. [YEAR:21-3-2003]Backman,D. and Danielson,U.H.
   Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans
   Biochim Biophys Acta1646, 184-195. PubMed  Europe PubMed DOI  I
6. Schaller,M., Bein,M., Korting,H.C., Baur,S., Hamm,G., Monod,M., Beinhauer,S. and Hube,B.
   The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium
   Infect Immun71, 3227-3234. PubMed  Europe PubMed DOI  I
2001
7. Pichova,I., Pavlickova,L., Dostal,J., Dolejsi,E., Hruskova-Heidingsfeldova,O., Weber,J., Ruml,T. and Soucek,M.
   Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors
   Eur J Biochem268, 2669-2677. PubMed  Europe PubMed DOI  I
8. Stewart,K. and Abad-Zapatero,C.
   Candida proteases and their inhibition: prospects for antifungal therapy
   Curr Med Chem8, 941-948. PubMed  Europe PubMed  I
1999
9. Borg-von Zepelin,M., Meyer,I., Thomssen,R., Wurzner,R., Sanglard,D., Telenti,A. and Monod,M.
   HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases
   J Invest Dermatol113, 747-751. PubMed  Europe PubMed DOI  I
10. Gruber,A., Berlit,J., Speth,C., Lass-Florl,C., Kofler,G., Nagl,M., Borg-von Zepelin,M., Dierich,M.P. and Wurzner,R.
    Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors
    Immunobiology201, 133-144. PubMed  Europe PubMed DOI  I
11. Korting,H.C., Schaller,M., Eder,G., Hamm,G., Bohmer,U. and Hube,B.
    Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-Infected patients
    Antimicrobial Agents Chemother43, 2038-2042. PubMed  Europe PubMed  I
12. Monod,M., Borg-von Zepelin,M., Telenti,A. and Sanglard,D.
    The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors
    Dermatology198, 412-414. PubMed  Europe PubMed  I
1992
13. Capobianco,J.O., Lerner,C.G. and Goldman,R.C.
    Application of a fluorogenic substrate in the assay of proteolytic activity and in the discovery of a potent inhibitor of Candida albicans aspartic proteinase
    Anal Biochem204, 96-102. PubMed  Europe PubMed DOI  I